Explore Our Biomarker Menu

Biomarker:

PRAS40 (total)

Biological or Clinical Significance:

The proline-rich Akt substrate of 40 kDa (PRAS40) acts at the intersection of the Akt- and mammalian target of rapamycin (mTOR)-mediated signaling pathways.PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. PRAS40 has been shown to regulate the activity of mammalian target of rapamycin complex 1 (mTORC1), which is a signaling hub connecting insulin signaling and autophagic signaling pathway. PRAS40 has received increasing attention as a potential therapeutic target for the treatment of insulin resistance as it has been demonstrated to reduce systemic hyperglycemia and ameliorate insulin sensitivity of obese mice.

References:

Analyte:

PRAS40 (total)

Matrix:

Status:

Experienced Running

Sensitivity-LLOQ:

Sensitivity-ULOQ:

platform

MSD-ECL

Required Sample Volume

Disease State:

MSD Panel:

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.


    Immunogenicity

    Learn why BioAgilytix is a world-leading authority on immunogenicity studies related to ADA, NAb assay development and validation, isotyping, and more.

    Case Studies

    Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.